We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort

    Introduction

    This study sought to analyze the benefit of an early induction therapy with a biological disease-modifying anti-rheumatic drugs (bDMARD)...

    Emilie Sapart, Tatiana Sokolova, ... Patrick Durez in Rheumatology and Therapy
    Article Open access 14 May 2023
  2. Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and sco** review

    Background

    To determine the prevalence of sustained remission/low disease activity (LDA) in patients with rheumatoid arthritis (RA) after...

    Michael M. Ward, Nima Madanchi, ... Florina Constantinescu in Arthritis Research & Therapy
    Article Open access 20 November 2023
  3. Increased gut permeability and intestinal inflammation precede arthritis onset in the adjuvant-induced model of arthritis

    Background

    Intestinal inflammation, dysbiosis, intestinal permeability (IP), and bacterial translocation (BT) have been identified in patients with...

    Sophie Hecquet, Perle Totoson, ... Frank Verhoeven in Arthritis Research & Therapy
    Article Open access 06 June 2023
  4. Inhibitory effects of Acanthopanax sessiliflorus Harms extract on the etiology of rheumatoid arthritis in a collagen-induced arthritis mouse model

    Background

    The biological function of Acanthopanax sessiliflorus Harm (ASH) has been investigated on various diseases; however, the effects of ASH on...

    Dahye Kim, Yunji Heo, ... Young-Ok Son in Arthritis Research & Therapy
    Article Open access 02 January 2024
  5. Immune mechanisms of depression in rheumatoid arthritis

    Depression is a common and disabling comorbidity in rheumatoid arthritis that not only decreases the likelihood of remission and treatment adherence...

    James Brock, Neil Basu, ... Jonathan Cavanagh in Nature Reviews Rheumatology
    Article 03 November 2023
  6. Some Drugs Have Two Faces: Paradoxical Colitis in a Patient with Psoriatic Arthritis Previously Treated with Etanercept and IL-17 Inhibitors

    Tumor necrosis factor-alpha (TNF-α) and interleukin-17 (IL-17) inhibitors are among the most potent treatments for inflammatory arthropathies...

    Sandy Huynh, Sudharshan Achalu, ... Alice G. Cheng in Digestive Diseases and Sciences
    Article 19 March 2024
  7. Treatment of systemic juvenile idiopathic arthritis

    Systemic juvenile idiopathic arthritis (sJIA) is an inflammatory disease with hallmarks of severe systemic inflammation, which can be accompanied by...

    Claas H. Hinze, Dirk Foell, Christoph Kessel in Nature Reviews Rheumatology
    Article 03 November 2023
  8. Targeting Therapeutic Windows for Rheumatoid Arthritis Prevention

    Rheumatoid arthritis (RA) is a worldwide public health problem. Interventions to delay or prevent the onset of RA have attracted much attention in...

    Kai-xin Gao, Yi-hong Yang, ... Run-yue Huang in Chinese Journal of Integrative Medicine
    Article 16 May 2024
  9. Immunologic derangement caused by intestinal dysbiosis and stress is the intrinsic basis of reactive arthritis

    Reactive arthritis (ReA) is defined as arthritis resulting from infections in other body parts, such as the gastrointestinal and urogenital tracts....

    Tao He, Weiqing Qian in Zeitschrift für Rheumatologie
    Article Open access 25 February 2024
  10. Differences between psoriatic arthritis and psoriasis in multi-omics

    We aim to systemically review the genomics, transcriptomics, epigenetics, proteomics, metabonomics and microbiota of psoriatic arthritis and...

    Siming Gao, Hui Song in Archives of Dermatological Research
    Article 24 May 2024
  11. Innate immune memory in inflammatory arthritis

    The concept of immunological memory was demonstrated in antiquity when protection against re-exposure to pathogens was observed during the plague of...

    Maxime M. Jeljeli, Iannis E. Adamopoulos in Nature Reviews Rheumatology
    Article 06 September 2023
  12. Dupilumab-Associated Arthritis: A Dermatology-Rheumatology Perspective

    Dupilumab is an interleukin (IL)-4/13 inhibitor approved by the US FDA for multiple atopic indications. It is well-known to have favorable efficacy...

    Michael J. Woodbury, Jeffrey S. Smith, Joseph F. Merola in American Journal of Clinical Dermatology
    Article 22 June 2023
  13. Microbial Mechanisms of Rheumatoid Arthritis Pathogenesis

    Purpose of Review

    Host-microbiome interactions have been implicated in the pathophysiology of rheumatoid arthritis (RA), but the data linking specific...

    Brenda J. Seymour, Brendan E. Allen, Kristine A. Kuhn in Current Rheumatology Reports
    Article 01 February 2024
  14. Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis

    In rheumatoid arthritis, juvenile idiopathic arthritis and other forms of inflammatory arthritis, the immune system targets certain joints but not...

    Margaret H. Chang, Robert C. Fuhlbrigge, Peter A. Nigrovic in Nature Reviews Rheumatology
    Article 10 April 2024
  15. Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs

    Introduction

    This post hoc analysis evaluated influenza adverse events (AEs) across rheumatoid arthritis (RA), ulcerative colitis (UC), and psoriatic...

    Kevin L. Winthrop, Arne Yndestad, ... Stanley B. Cohen in Rheumatology and Therapy
    Article Open access 17 December 2022
  16. Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis

    Background

    Synovial fibroblasts in rheumatoid arthritis (RAFLS) exhibit a pathological aberration of glycolysis and glutaminolysis. Henceforth, we...

    Shanzay Ahmed, Christopher B. Mahony, ... Monica Guma in Arthritis Research & Therapy
    Article Open access 20 September 2023
  17. Natural compound library screening to identify berberine as a treatment for rheumatoid arthritis

    Objective

    Fibroblast-like synoviocytes (FLS) play a critical role on the exacerbation and deterioration of rheumatoid arthritis (RA). Aberrant...

    Li Zhang, Min Tan, ... Hai-Li Shen in Clinical Rheumatology
    Article 02 February 2024
  18. Baricitinib ameliorates inflammatory and neuropathic pain in collagen antibody-induced arthritis mice by modulating the IL-6/JAK/STAT3 pathway and CSF-1 expression in dorsal root ganglion neurons

    Background

    Janus kinase (JAK) inhibitors, such as baricitinib, are widely used to treat rheumatoid arthritis (RA). Clinical studies show that...

    Kenta Makabe, Hiroyuki Okada, ... Taku Saito in Arthritis Research & Therapy
    Article Open access 15 June 2024
  19. Matrix metalloproteinases in arthritis: towards precision medicine

    Proteolysis of structural molecules of the extracellular matrix (ECM) is an irreversible post-translational modification in all arthropathies. Common...

    Bernard Grillet, Rafaela Vaz Sousa Pereira, ... Ghislain Opdenakker in Nature Reviews Rheumatology
    Article 09 May 2023
  20. Drug- or Vaccine-Induced/Aggravated Psoriatic Arthritis: A Systematic Review

    Introduction

    Drugs and vaccines have been less studied as inducing or aggravating factors for psoriatic arthritis (PsA) compared with psoriasis. Thus,...

    Yao-Tsung Yeh, Tsen-Fang Tsai in Dermatology and Therapy
    Article Open access 06 January 2024
Did you find what you were looking for? Share feedback.